Stocks Close Higher as Geopolitical Anxiety Eases The S&P 500 SPY$655.43▲ 0.82% ended the session up 0.82%, capturing a relief rally fueled by hopes for a de-escalation in the Middle East. While a significant overnight gap higher set the stage for the day, the market largely consolidated those gains, ultimately finishing the session on a constructive note.

Healthcare was a major engine for growth, with LLY$941.94▲ 2.41% jumping on long-awaited FDA approval for its latest weight-loss treatment. Meanwhile, the AI ecosystem continues to dominate the broader narrative; despite recent scrutiny over infrastructure spending, heavy capital flows—including Microsoft's MSFT$371.13▲ 0.27% strategic alignments—are sustaining investor risk appetite. However, the mood remains selective. While semiconductor names like NVIDIA NVDA$175.86▲ 0.83% and TSLA$380.00▲ 2.23% face individual headwinds ranging from competitive pressure to delivery concerns, defensive positioning persists among institutional fund managers as reflected in the latest Bank of America survey. Markets now shift focus to upcoming macroeconomic data and whether the current valuation reset signals a true recovery or merely a tactical bounce.

Stocks Maintain Gains as AI and Pharma Strength Prevail The S&P 500 (SPY$654.29▲ 0.64%) is up 0.66% on the day, holding at $654.42. Despite gapping up 0.69% overnight, the index has largely consolidated those gains, trading essentially flat from this morning’s opening bell as investors parse a heavy flow of sector-specific news.

The tech landscape remains in flux. While ORCL$144.82▼ 1.57% is finding support following a massive $16B data center financing deal, NVDA$175.52▲ 0.64% and AMD AMD$211.11▲ 3.86% are facing downward pressure as new industry data suggests their dominance in the Chinese AI accelerator market is eroding rapidly. Meanwhile, the consumer discretionary space is feeling the heat; NKE is sliding after multiple analyst downgrades highlighted deepening weakness in China and a sluggish turnaround, and RH RH has plunged toward a six-year low, signaling that even high-end luxury spending is beginning to crack. Elsewhere, MSC MSM shares are under pressure following reports of ongoing sales challenges, and Alexandria Real Estate Equities (ARE) has hit a 52-week low.

Stocks Extend Gains as AI and Pharma Catalysts Lead The S&P 500 (SPY$657.53▲ 1.14%) is up 1.15% on the day, holding firmly at $657.58. Following a 0.69% overnight gap higher, the market has maintained its footing, driven by a wave of high-impact corporate developments.

Healthcare is outperforming after LLY$961.92▲ 4.59% received FDA approval for its new GLP-1 weight-loss pill, Foundayo. In the semiconductor space, MU is enjoying a massive rally, adding over $43 billion in market cap as investors bank on a memory cycle recovery. Meanwhile, AMZN$212.21▲ 1.83% and MSFT$372.00▲ 0.51% continue to draw institutional support, with Wall Street bullish on their AI infrastructure positioning, including a significant joint data center venture with CVX$191.31▼ 7.55%.

Markets are also absorbing rumors of a confidential IPO filing by SpaceX, which could mark a historic valuation event. While MS$162.89▼ 1.01% warns of potential Q1 earnings estimate revisions, the prevailing sentiment remains buoyant, with analysts upgrading GOOGL$299.54▲ 4.20% on cloud monetization prospects.

Stocks Extend Gains on Pharma and AI Catalysts The S&P 500 (SPY$657.88▲ 1.19%) is up 1.20% on the day, trading at $657.92. Following a 0.69% overnight gap, the market has maintained a steady climb as investors cheer major corporate developments despite lingering geopolitical risks.

Healthcare is a standout performer, led by LLY$961.45▲ 4.54%, which is surging following FDA approval of its new GLP-1 weight-loss pill, Foundayo. Meanwhile, the AI ecosystem continues to command massive capital inflows, highlighted by OpenAI securing $122 billion in funding at a staggering $852 billion valuation, with backing from AMZN$212.89▲ 2.16%, NVDA$176.74▲ 1.34%, and SoftSFTBY. Adding to the bullish narrative, reports confirm that SpaceX has filed for a record-breaking IPO, potentially hitting the markets as early as June.

On the downside, AAPL$254.83▲ 0.43% remains under pressure after a Chinese court ruling upheld key AI patent claims against the tech giant. Meanwhile, PZZA is facing scrutiny following a strategic menu overhaul as the company attempts to combat industry-wide headwinds. Elsewhere, WDC is attracting buyers on a Bernstein upgrade, even as the sector reconciles with new AI memory efficiency breakthroughs from GOOGL$298.35▲ 3.78%.